To explore effects of DNA damage on cell-cycle progression in p53-deficient tumor cells, synchronized HeLa cells at G1, S and G2/M phases were treated with methyl methanesulfnate (MMS). The resultsshowed that the MMS treatment resulted in the cell-cycle arrest or delay in all 3 phases, while the S-phase cells were the most sensitive to MMS. Further studies demonstrated that ATM-Chk2 and p38 MAPK signaling pathways were activated in all 3 phases when the cells were treated with MMS; whereas Chk1 was activated only in S phase under the drug treatment, indicating that Chk1 specifically participated in S-phase checkpoints. To analyze the role of Chk1 in S-phase checkpoints, we administered a specific Chk1 inhibitor, UCN-01, to the S-phase cells. The results showed that the S-phase cells treated with MMS+UCN-01 could enter aberrant mitosis without finishing DNA replication, indicating that Chk1 mainly functions in the DNA damage checkpoint rather than in the replication checkpoint. In addition, MMS treatment alone inhibited the accumulation of cyclin B1, a key component of M-phase CDK-cyclin complex, in the S-phase cells, whereas the inhibition of Chk1 activation resulted in the accumulation of cyclin B1 in the MMS-treated S-phase cells. This observation further supports the view that DNA-damaged S-phase cells enter abnormal mitosis when Chk1 activation is inhibited. Our results demonstrate that Chk1 is a specific kinase that plays an important role in the MMS-induced S-phase DNA damage checkpoint. As p53 is not involved in this process, Chk1 may be a potential target for p53-deficient tumor therapy. cell cycle, DNA damage checkpoint, DNA replication checkpoint, Chk1, methyl methanesulfnate During the evolutionary process, cells have developed molecular regulatory pathways called checkpoints to control the quality of cell proliferation. There are 3 types of checkpoints: (i) The DNA damage checkpoint responsible for checking DNA damage; (ii) the DNA replication checkpoint checking whether DNA is replicated normally; and (iii) the spindle assembly checkpoint, which checks the quality of chromosome segregation [1,2] .The DNA damage checkpoint is biochemical pathways that delay or arrest cell cycle progression in response to genomic DNA damage. Since DNA damage may occur at any phase of a cell cycle, there exist G1, S and G2/M DNA damage checkpoints respectively. A number of studies have revealed that different molecular mechanisms correspond to DNA damage checkpoints at different phases [3,4] , and ATR/Chk1 and ATM/Chk2 signaling pathways especially play important roles [5] . The ATM/Chk2 pathway is activated when the genome is damaged by DNA double-strand breaks [6] , while the ATR/Chk1 pathway mainly functions in the case of DNA single-stranded breaks (SSB) or structural damage